You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK – Revolution Medicines today said that it has raised $100 million in a Series C financing round to support its pipeline of oncology drugs focused on specific pathways.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.